Literature DB >> 9754670

Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa.

A Kwara1, R A Adegbola, P T Corrah, M Weber, M Achtman, G Morelli, D A Caugant, B M Greenwood.   

Abstract

Meningococci belonging to serogroup W135 caused several cases of meningococcal meningitis in The Gambia in 1995 and were isolated during a serogroup A epidemic in Mali in 1994. The eight isolates tested belonged to the same clone of the ET-37 complex and differed in several bands from the pulsed-field gel electrophoresis restriction pattern of serogroup C meningococci of the ET-37 complex isolated in Mali. Three of 6 patients infected in The Gambia died, indicating that this W135 clone is virulent. Vaccines that protect only against infections with meningococci belonging to serogroups A and C are usually used to control outbreaks in Africa, although vaccines containing the W135 polysaccharide are available. The findings of this study indicate that outbreaks of meningococcal meningitis in Africa can be associated with serogroup W135 infections and that serogrouping is essential before vaccination campaigns are started.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754670     DOI: 10.1046/j.1365-3156.1998.00300.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  21 in total

1.  Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis.

Authors:  P Zhu; A van der Ende; D Falush; N Brieske; G Morelli; B Linz; T Popovic; I G Schuurman; R A Adegbola; K Zurth; S Gagneux; A E Platonov; J Y Riou; D A Caugant; P Nicolas; M Achtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.

Authors:  Muhamed-Kheir Taha; Isabelle Parent Du Chatelet; Martin Schlumberger; Idrissa Sanou; Saacou Djibo; François de Chabalier; Jean-Michel Alonso
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Meningococcal group C conjugate vaccines.

Authors:  J Maclennan
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

4.  Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors:  Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

5.  The changing face of meningococcal disease in West Africa.

Authors:  B Greenwood
Journal:  Epidemiol Infect       Date:  2007-07       Impact factor: 2.451

6.  Ultrasound enhanced detection of individual meningococcal serogroups by latex immunoassay.

Authors:  M A Sobanski; R Vince; G A Biagini; C Cousins; M Guiver; S J Gray; E B Kaczmarski; W T Coakley
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

Review 7.  The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology.

Authors:  Vanessa N Racloz; Silva J D Luiz
Journal:  BMC Infect Dis       Date:  2010-06-17       Impact factor: 3.090

8.  Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon.

Authors:  Marie-Christine Fonkoua; Muhamed-Kheir Taha; Pierre Nicolas; Patrick Cunin; Jean-Michel Alonso; Raymond Bercion; Jeanne Musi; Paul M V Martin
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

9.  Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.

Authors:  Muhamed-Kheir Taha; Dario Giorgini; Magaly Ducos-Galand; Jean-Michel Alonso
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.